Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea
· Delayed Price · Currency is KRW 9,040.00
-110.00 (-1.20%)
Apr 29, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 111.59 billion as of April 29, 2026. Its market cap has decreased by -13.14% in one year.
Market Cap
111.59B
Enterprise Value
93.52B
Revenue
370.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,040.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 111.59B, an increase of 5.03%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 110.25B | -4.32% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMB Dx | 102.61B |
| CG Invites | 98.96B |
| iNtRON Biotechnology | 120.13B |
| GeneOne Life Science | 91.67B |
| Amicogen | 131.18B |
| ORIENT BIO | 66.04B |
| ENCell | 176.61B |
| Vaxcell-Bio Therapeutics | 181.17B |